Nanophase Announces Successful Litigation Settlement
ROMEOVILLE, Ill., April 11, 2024 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB:NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — announced today that it has agreed to a successful and amicable resolution of all ongoing litigation with BASF. The parties have executed a Settlement Agreement, an amendment to their existing supply contract, and a joint stipulation to dismiss the case with prejudice to be filed in the Superior Court of New Jersey within the next five business days.
Related news for (NANX)
- Nanophase Reports Record Second Quarter Revenue and Profit
- Nanophase Technologies Announces Second Quarter 2024 Financial Release and Conference Call Details
- Solésence Beauty Science Wins Cosmopack North America Formulation Award for Third Year in a Row
- Solésence Beauty Science and other Chicago Innovation Awards Winners to Ring the Nasdaq Opening Bell
- Nanophase Reports Record First Quarter Results